The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) is a clinical study sponsored by the National Heart, Lung, and Blood Institute (NHLBI). PrecISE's physician scientists are dedicated to researching better treatments for people living with severe asthma.
PrecISE is a clinical study that uses precision medicine for severe asthma. Precision medicine is an approach to the prevention and treatment of disease that uses information about an individual's or group's specific disease process, symptoms, and treatment responses, to identify the medicines and therapies that are most likely to be effective for them.
Researchers from over 30 locations across the US are involved in PrecISE.
Contact Us
Participants should contact their local study site if they have questions regarding the study by clicking the map below.
General questions about PrecISE can be directed to:
The PrecISE Data, Modeling, and Coordination Center
The University of North Carolina - Chapel Hill
precise@unc.edu
PrecISE
123 W. Franklin Street
Suite 450
Chapel Hill, NC 27516